David D. O'Toole - 14 Sep 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Chief Financial Officer
Signature
/s/ David D. O'Toole
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
+$3,824
Form type
4
Filing time
15 Sep 2021, 16:02:58 UTC
Previous filing
16 Aug 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $3,424 +179 +0.75% $19.13 23,994 14 Sep 2021 Direct
transaction OPNT Common Stock Purchase $400 +21 +0.09% $19.05 24,015 14 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.